Literature DB >> 34171923

Correlation Between Trans-Stenotic Blood Flow Velocity Differences and the Cerebral Venous Pressure Gradient in Transverse Sinus Stenosis: A Prospective 4-Dimensional Flow Magnetic Resonance Imaging Study.

Heyu Ding1, Pengfei Zhao1, Han Lv1, Xiaoshuai Li1, Xiaoyu Qiu1, Rong Zeng2, Guopeng Wang2, Zhenghan Yang1, Shusheng Gong2, Long Jin3, Zhenchang Wang1.   

Abstract

BACKGROUND: The relationship between trans-stenotic blood flow velocity differences and the cerebral venous pressure gradient (CVPG) in transverse sinus (TS) stenosis (TSS) has not been studied.
OBJECTIVE: To evaluate the hemodynamic manifestations of TSS and the relationship between trans-stenotic blood flow velocity differences and the CVPG.
METHODS: Thirty-three patients with idiopathic intracranial hypertension (IIH) or pulsatile tinnitus (PT) and TSS who had undergone diagnostic venography using venous manometry were included in the patient group. Thirty-three volunteers with no stenosis and symptoms were included in the control group. All the 2 groups underwent prospective venous sinus 4-dimensional (4D) flow magnetic resonance imaging (MRI). The average velocity (Vavg) difference and maximum velocity (Vmax) difference between downstream and upstream of the TS in 2 groups were measured and compared. Correlations between the CVPG and trans-stenotic Vavg difference/Vmax difference/index of transverse sinus stenosis (ITSS) were assessed in the patient group.
RESULTS: The differences in Vavg difference and Vmax difference between the patient and control groups showed a statistical significance (P < .001). The Vavg difference and Vmax difference had a strong correlation with CVPG (R = 0.675 and 0.701, respectively, P < .001) in the patient group. Multivariate linear regression using the stepwise method showed that the Vmax difference and ITSS were correlated with the CVPG (R = 0.752 and R2 = 0.537, respectively; P < .001).
CONCLUSION: The trans-stenotic blood flow velocity difference significantly correlates with the CVPG in TSS. As a noninvasive imaging modality, 4D flow MRI may be a suitable screening or complimentary tool to decide which TSS may benefit from invasive venous manometry. © Congress of Neurological Surgeons 2021.

Entities:  

Keywords:  Blood flow velocity; Hemodynamics; Idiopathic intracranial hypertension; Magnetic resonance imaging; Manometry; Tinnitus; Venous pressure

Year:  2021        PMID: 34171923     DOI: 10.1093/neuros/nyab222

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

Review 1.  Cerebral Venous Outflow Implications in Idiopathic Intracranial Hypertension-From Physiopathology to Treatment.

Authors:  Sorin Tuță
Journal:  Life (Basel)       Date:  2022-06-08

2.  Prediction of the trans-stenotic pressure gradient with arteriography-derived hemodynamic features in patients with idiopathic intracranial hypertension.

Authors:  Yupeng Zhang; Chao Ma; Changxuan Li; Xiaoqing Li; Raynald Liu; Minke Liu; Haoyu Zhu; Fei Liang; Yilong Wang; Kehui Dong; Chuhan Jiang; Zhongrong Miao; Dapeng Mo
Journal:  J Cereb Blood Flow Metab       Date:  2022-03-08       Impact factor: 6.960

3.  Evidence of air-conduction transmission pathway and strategized transtemporal operative techniques for venous pulsatile tinnitus: Combining water occlusion test and operative sensing applications.

Authors:  Yue-Lin Hsieh; Xiaobing Xu; Yongzhen Wu; Wuqing Wang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-15

4.  Retroauricular/Transcranial Color-Coded Doppler Ultrasound Approach in Junction With Ipsilateral Neck Compression on Real-Time Hydroacoustic Variation of Venous Pulsatile Tinnitus.

Authors:  Xiuli Gao; Yue-Lin Hsieh; Xing Wang; Wuqing Wang
Journal:  Front Hum Neurosci       Date:  2022-06-15       Impact factor: 3.473

5.  Intracranial pressure, lateral sinus patency, and jugular ultrasound hemodynamics in patients with venous pulsatile tinnitus.

Authors:  Xiuli Gao; Yue-Lin Hsieh; Shenjiang Wang; Suming Shi; Wuqing Wang
Journal:  Front Neurol       Date:  2022-09-16       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.